Brief: TCR2 Therapeutics Files For Mixed Shelf Offering Of Up To $300 Mln
06/03/2020 22:49
March 6 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR2 THERAPEUTICS FILES FOR MIXED SHELF OFFERING OF UP TO
$300
MILLION - SEC FILING
Source text: (http://bit.ly/2uZYhnU)
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview